SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice

A Novel Chemometric Method for the Prediction of Human Oral Bioavailability

Xue Xu, Wuxia Zhang, Chao Huang et al. · International Journal of Molecular Sciences · 2012 · 843 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Lucía Barbier‐Torres, Karen A. Fortner, Paula Iruzubieta et al. · Nature Communications · 2020 · 146 citations · Full text

Life Sciences, Molecular Medicine, Pharmacology +17

Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway

Liwei Wu, Wenhui Mo, Jiao Feng et al. · British Journal of Pharmacology · 2020 · 144 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018

Lin Mu, Jiamin Liu, Guohai Zhou et al. · Circulation Cardiovascular Quality and Outcomes · 2021 · 98 citations · Full text

Public Health, Population Health Sciences, Public Health Nutrition +14

Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)

Saima Ajaz, Mark McPhail, Luigi Gnudi et al. · Mitochondrion · 2020 · 88 citations

Life Sciences, Biochemistry, Molecular Medicine +12